Zacks Investment Research lowered shares of Halyard Health (NYSE:HYH) from a strong-buy rating to a hold rating in a research report sent to investors on Tuesday.
According to Zacks, “Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. “
Other equities research analysts have also issued reports about the company. TheStreet raised Halyard Health from a c+ rating to a b rating in a research report on Monday, December 4th. ValuEngine raised Halyard Health from a hold rating to a buy rating in a research note on Sunday, December 31st. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company currently has a consensus rating of Buy and an average target price of $49.33.
Halyard Health (NYSE:HYH) last issued its earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.23. Halyard Health had a return on equity of 6.98% and a net margin of 5.82%. The firm had revenue of $428.10 million for the quarter, compared to analyst estimates of $413.94 million. During the same period last year, the company earned $0.50 earnings per share. The firm’s revenue for the quarter was up 4.4% on a year-over-year basis. equities analysts anticipate that Halyard Health will post 0.96 EPS for the current fiscal year.
Several large investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP grew its stake in shares of Halyard Health by 5.1% in the third quarter. Dimensional Fund Advisors LP now owns 3,292,483 shares of the medical instruments supplier’s stock worth $148,262,000 after purchasing an additional 159,434 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Halyard Health by 5.6% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,709,355 shares of the medical instruments supplier’s stock worth $78,938,000 after purchasing an additional 91,378 shares in the last quarter. Paradice Investment Management LLC grew its stake in shares of Halyard Health by 2.1% in the third quarter. Paradice Investment Management LLC now owns 1,564,813 shares of the medical instruments supplier’s stock worth $70,464,000 after purchasing an additional 31,832 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Halyard Health by 4.0% in the fourth quarter. Bank of New York Mellon Corp now owns 918,798 shares of the medical instruments supplier’s stock worth $42,429,000 after purchasing an additional 35,688 shares in the last quarter. Finally, Macquarie Group Ltd. grew its stake in shares of Halyard Health by 103.0% in the fourth quarter. Macquarie Group Ltd. now owns 859,281 shares of the medical instruments supplier’s stock worth $39,681,000 after purchasing an additional 435,935 shares in the last quarter. 90.45% of the stock is owned by institutional investors.
COPYRIGHT VIOLATION NOTICE: This story was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are reading this story on another publication, it was stolen and republished in violation of United States & international trademark & copyright laws. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3252300/halyard-health-hyh-rating-lowered-to-hold-at-zacks-investment-research-2.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.